REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

REPRODIVAC Community at the IVVN Conference 2024: Strengthening Global Collaboration in Veterinary Vaccinology

REPRODIVAC Community at the  International Veterinary Vacccinology Network (IVVN https://www.intvetvaccnet.co.uk/) Conference 2024: Strengthening Global Collaboration in Veterinary Vaccinology.

The REPRODIVAC community, including partners from the Pirbright Institute (TPI), Moredun Research (MRI), Centro de Investigacion y Tecnologia Agroalimentaria de Aragon (CITA), and the University of Navarra (UON), was attending the International Veterinary Vaccinology Network (IVVN) Conference 2024, held on 9-10 November in Ho Chi Minh City, Vietnam. This important event, hosted in partnership with the Biotechnology Center of Ho Chi Minh City, provided a unique opportunity for global experts in veterinary vaccinology to share insights, discuss recent advancements, and forge new collaborations.

The conference focused on the development of vaccines for livestock and zoonotic diseases, particularly in low-and-middle income countries (LMICs). It was a key moment for the REPRODIVAC community to present the latest findings from its research, alongside a wide range of exciting new projects and innovative techniques in the field of animal vaccines.

With presentations from invited speakers, abstract-based talks, networking sessions, and a poster session, the IVVN conference offered a dynamic and productive environment for the global veterinary community to come together. The REPRODIVAC teams found it to be a valuable opportunity to deepen collaborations within the project and expand connections with other experts, all while contributing to the shared mission of improving animal health and disease prevention worldwide.

This conference also underscored the importance of international cooperation and knowledge exchange in the pursuit of effective vaccines for animal health, with a particular emphasis on the challenges and opportunities in LMICs.

As the REPRODIVAC project continues to progress, these exchanges will be crucial in helping shape the future of veterinary vaccinology and ensuring that cutting-edge research translates into tangible benefits for both animal and public health.

Reprodivac representatives at IVVN 2024 From left ro right Simon Graham (TPI), Pilar Munoz (CITA), Raquel Conde-Alvarez (UON), Sean Wattegedera (MRI), Vish Nene (REPRODIVAC Scientific Advisor)
IVVN2024 participants Picture of all the conference participants
Pilar Munoz (left) and Raquel Conde-Alvarez (right) presenting activities developed within REPRODIVAC
Pilar Munoz at IVVN 2024
Raquel Conde-Alvarez at IVVN 2024

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

Feedback